Related Experiment Video
Updated: Oct 18, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Duodenal Mucosal Barrier in Functional Dyspepsia
Susrutha Puthanmadhom Narayanan1, Daniel R O'Brien2, Mayank Sharma1
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
In functional dyspepsia (FD), microRNAs may reduce duodenal barrier proteins, increasing intestinal permeability. This study found reduced barrier proteins and higher permeability in FD patients.
Area of Science:
- Gastroenterology
- Molecular Biology
- Physiology
Background:
- Functional dyspepsia (FD) involves gastric issues and potential duodenal micro-inflammation.
- Epithelial barrier dysfunction in the duodenum is observed in FD, but its cause and significance are unclear.
- This study investigates the role of microRNAs (miRNAs) and inflammation in degrading duodenal epithelial barrier proteins.
Purpose of the Study:
- To determine if miRNAs and/or inflammation degrade duodenal epithelial barrier proteins in FD.
- To assess if this degradation leads to increased duodenal mucosal permeability in FD patients.
Main Methods:
- Compared duodenal gene expression, miRNA profiles, and in vivo permeability (lactulose-mannitol test) in 40 FD patients and 24 controls.
- Performed ex vivo assessments of transmucosal resistance and fluorescein isothiocyanate (FITC)-dextran flux.
- Analyzed duodenal histology using light and electron microscopy.
Main Results:
- FD patients showed reduced mRNA expression of barrier proteins (zonula occludens-1, occludin, claudin-12, E-cadherin) compared to controls.
- Increased expression of specific miRNAs (miR-142-3p, miR-144-3p) that target these barrier protein genes was observed in FD.
- FD patients exhibited increased in vivo small intestinal permeability, indicated by higher urinary lactulose excretion and lactulose:mannitol ratio.
Conclusions:
- Functional dyspepsia is associated with a modest reduction in duodenal epithelial barrier proteins.
- Up-regulation of specific miRNAs may contribute to the reduced expression of these barrier proteins in FD.
- Increased small intestinal permeability is a feature of functional dyspepsia.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

